Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Update on the application of monoclonal antibody therapy in primary membranous nephropathy
L Deng, G Xu - Drugs, 2023 - Springer
When first introduced, rituximab (RTX), a chimeric anti-CD20 monoclonal antibody, brought
about an alternative therapeutic paradigm for primary membranous nephropathy (PMN) …
about an alternative therapeutic paradigm for primary membranous nephropathy (PMN) …
Targeted nanotherapy for kidney diseases: a comprehensive review
Kidney diseases represent a major public health problem, affecting millions of people
worldwide. Moreover, the treatment of kidney diseases is burdened by the problematic …
worldwide. Moreover, the treatment of kidney diseases is burdened by the problematic …
[HTML][HTML] Ofatumumab in rituximab-resistant and rituximab-intolerant patients with primary membranous nephropathy: a case series
Rationale & Objective Rituximab is the first-choice therapy for patients with primary
membranous nephropathy (MN) and nephrotic syndrome. However, approximately 30% of …
membranous nephropathy (MN) and nephrotic syndrome. However, approximately 30% of …
Sexual dimorphic response to rituximab treatment: A longitudinal observational study in a large cohort of patients with primary membranous nephropathy and …
Rituximab is one of the first-line therapies for patients with membranous nephropathy (MN)
at high risk of progression towards kidney failure. We investigated whether the response to …
at high risk of progression towards kidney failure. We investigated whether the response to …
Disease-Specific Treatment for Primary Membranous Nephropathy: The Role of Monoclonal Antibodies
Abstract Primary Membranous Nephropathy is an autoimmune disease caused by the
deposition of Immunoglobulin G and complement components on the subepithelial layer of …
deposition of Immunoglobulin G and complement components on the subepithelial layer of …
Therapieansprechen und Komplikationen unter Therapie mit dem B-Zell Antikörper Rituximab bei Minimal Change Glomerulopathie (MCD), primärer fokal …
M Schaepe - 2024 - db-thueringen.de
Glomerulonephritiden sind zumeist autoimmun vermittelte, entzündliche Erkrankungen der
glomerulären Kapillaren in der Niere und stellen bei 20% aller Patienten mit chronischer …
glomerulären Kapillaren in der Niere und stellen bei 20% aller Patienten mit chronischer …
Clinical Evaluation of Pediatric Patients Diagnosed with Membranous Glomerulonephritis
Objective: Membranous nephropathy (MN) is a rare immune complex disease in pediatric
population then adults. The prognosis of MN is variable, ranging from spontaneous …
population then adults. The prognosis of MN is variable, ranging from spontaneous …
[PDF][PDF] 利妥昔单抗致听力, 视力损伤及腹部皮肤隆起一例
牛倩倩， 潘丰德， 邱雯 - Clinical Medication Journal, 2024 - lcywzlzz.com
本文报道1 例53 岁女性患者因膜性肾病使用利妥昔单抗治疗后, 出现听力下降,
视力模糊以及下腹部皮肤隆起, 考虑为利妥昔单抗所致的不良反应. 停用利妥昔单抗40 d 后 …
视力模糊以及下腹部皮肤隆起, 考虑为利妥昔单抗所致的不良反应. 停用利妥昔单抗40 d 后 …